Baumal Caroline 4
4 · Apellis Pharmaceuticals, Inc. · Filed Jan 5, 2023
Insider Transaction Report
Form 4
Baumal Caroline
Chief Medical Officer
Transactions
- Award
Common Stock
2023-01-03+35,549→ 35,682.37 total - Award
Stock Option (Right to Buy)
2023-01-03$50.28/sh+49,000$2,463,720→ 49,000 totalExercise: $50.28Exp: 2033-01-02→ Common Stock (49,000 underlying)
Footnotes (2)
- [F1]This represents a Restricted Stock Unit award granted on 01/03/2023 that vest 25% annually over four years from grant date subject to continued service.
- [F2]This represents a stock option was granted on 01/03/2023 and has a four year vesting period. 25% vest one year from grant and then monthly thereafter subject to continued service.